Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 477,905 | 298,490 | 334,517 | 350,736 | 306,681 |
| Marketable Securities | 59,125 | 59,431 | 59,451 | 29,743 | 118,402 |
| Receivables | 6,561 | 5,763 | 4,869 | 4,022 | 3,409 |
| TOTAL | $570,038 | $396,641 | $421,694 | $411,215 | $455,481 |
| Non-Current Assets | |||||
| PPE Net | 487 | 532 | 577 | 622 | 667 |
| Other Non-Current Assets | 3,422 | 3,201 | 2,162 | 2,498 | 3,948 |
| TOTAL | $3,909 | $3,733 | $2,739 | $3,120 | $4,615 |
| Total Assets | $573,947 | $400,374 | $424,433 | $414,335 | $460,096 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,038 | 23,380 | 29,553 | 25,282 | 17,079 |
| Accrued Expenses | 27,108 | 21,814 | 14,691 | 21,587 | 8,732 |
| TOTAL | $45,392 | $46,114 | $45,478 | $48,368 | $27,361 |
| Non-Current Liabilities | |||||
| Long Term Debt | 99,514 | 99,018 | 74,100 | 73,741 | 73,381 |
| Other Non-Current Liabilities | 846 | 1,218 | 966 | 2,000 | 2,241 |
| TOTAL | $100,360 | $100,236 | $74,474 | $74,776 | $74,791 |
| Total Liabilities | $145,752 | $146,350 | $119,952 | $123,144 | $102,152 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 85,107 | 73,615 | 71,728 | 64,231 | 64,231 |
| Common Shares | 8 | 7 | 7 | 6 | 6 |
| Retained earnings | -594,423 | -532,618 | -462,911 | -400,486 | -330,757 |
| Other shareholders' equity | 630 | 322 | 604 | 2,563 | 4,733 |
| TOTAL | $428,195 | $254,024 | $304,481 | $291,191 | $357,944 |
| Total Liabilities And Equity | $573,947 | $400,374 | $424,433 | $414,335 | $460,096 |